Opaleye Management as of Dec. 31, 2019
Portfolio Holdings for Opaleye Management
Opaleye Management holds 47 positions in its portfolio as reported in the December 2019 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Epizyme | 6.7 | $34M | 1.4M | 24.60 | |
Aptose Biosciences | 4.5 | $23M | 4.1M | 5.67 | |
Codexis (CDXS) | 4.4 | $22M | 1.4M | 15.92 | |
Forty Seven | 4.3 | $22M | 562k | 39.37 | |
Stereotaxis (STXS) | 4.3 | $22M | 4.1M | 5.36 | |
Turning Point Therapeutics I | 4.2 | $21M | 341k | 62.29 | |
Ocular Therapeutix (OCUL) | 4.0 | $20M | 5.1M | 3.95 | |
Imprimis Pharmaceuticals | 3.6 | $18M | 2.3M | 7.78 | |
Eidos Therapeutics | 3.5 | $18M | 316k | 57.39 | |
Audentes Therapeutics | 3.4 | $18M | 292k | 59.84 | |
Neoleukin Therapeutics | 3.3 | $17M | 1.4M | 12.32 | |
Uniqure Nv (QURE) | 3.0 | $15M | 210k | 71.66 | |
Amarin Corporation (AMRN) | 2.8 | $14M | 665k | 21.44 | |
Intra Cellular Therapies (ITCI) | 2.7 | $14M | 407k | 34.31 | |
Deciphera Pharmaceuticals (DCPH) | 2.7 | $14M | 225k | 62.24 | |
Chemocentryx | 2.7 | $14M | 362k | 38.29 | |
Axogen (AXGN) | 2.5 | $13M | 700k | 17.89 | |
Cerecor | 2.3 | $12M | 2.2M | 5.39 | |
Odonate Therapeutics Ord | 2.3 | $12M | 355k | 32.45 | |
Eton Pharmaceuticals (ETON) | 2.1 | $11M | 1.5M | 7.20 | |
Xoma Corp Del (XOMA) | 2.0 | $10M | 374k | 27.30 | |
Avenue Therapeutics | 1.9 | $9.9M | 1.0M | 9.60 | |
Fortress Biotech | 1.9 | $9.8M | 3.8M | 2.57 | |
Ptc Therapeutics I (PTCT) | 1.8 | $9.2M | 191k | 48.03 | |
Biohaven Pharmaceutical Holding | 1.8 | $9.0M | 165k | 54.44 | |
ACADIA Pharmaceuticals (ACAD) | 1.7 | $8.8M | 207k | 42.78 | |
Flexion Therapeutics | 1.7 | $8.6M | 416k | 20.70 | |
Blueprint Medicines (BPMC) | 1.6 | $8.0M | 100k | 80.01 | |
Zymeworks | 1.6 | $8.0M | 175k | 45.46 | |
Edap Tms (EDAP) | 1.6 | $7.9M | 1.8M | 4.43 | |
Tricida | 1.4 | $7.3M | 194k | 37.64 | |
Magenta Therapeutics | 1.3 | $6.7M | 450k | 14.95 | |
Ra Pharmaceuticals | 1.3 | $6.7M | 142k | 46.93 | |
Crinetics Pharmaceuticals In (CRNX) | 1.3 | $6.7M | 266k | 25.09 | |
Tg Therapeutics (TGTX) | 1.3 | $6.4M | 580k | 11.10 | |
Fibrogen (FGEN) | 1.2 | $6.3M | 146k | 42.89 | |
Achillion Pharmaceuticals | 0.9 | $4.6M | 760k | 6.03 | |
Kadmon Hldgs | 0.8 | $4.3M | 940k | 4.53 | |
Aquestive Therapeutics (AQST) | 0.8 | $4.3M | 739k | 5.82 | |
Radius Health | 0.7 | $3.4M | 168k | 20.16 | |
Quanterix Ord (QTRX) | 0.6 | $3.1M | 132k | 23.63 | |
Rhythm Pharmaceuticals (RYTM) | 0.5 | $2.5M | 111k | 22.96 | |
Tela Bio (TELA) | 0.4 | $2.3M | 175k | 12.95 | |
Macrogenics (MGNX) | 0.4 | $2.2M | 201k | 10.88 | |
Fennec Pharmaceuticals (FENC) | 0.0 | $78k | 12k | 6.50 | |
Biolinerx Ltd-spons | 0.0 | $38k | 17k | 2.28 | |
Proteon Therapeutics | 0.0 | $75k | 188k | 0.40 |